लोड हो रहा है...
Docetaxel-based chemotherapy as second-line regimen for advanced thymic carcinoma
Thymic carcinoma is an uncommon neoplasm. The efficacy of second-line treatment with docetaxel in advanced thymic carcinoma has not been well studied. Therefore, we conducted a review of the efficacy of docetaxel-based chemotherapy as a second-line regimen for advanced thymic carcinoma. Fifteen pati...
में बचाया:
| में प्रकाशित: | Thorac Cancer |
|---|---|
| मुख्य लेखकों: | , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
BlackWell Publishing Ltd
2014
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4704314/ https://ncbi.nlm.nih.gov/pubmed/26766995 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12064 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|